A Phase 1 Study to Evaluate the Effects of Fluconazole and Atorvastatin on the Pharmacokinetics of TAK-385 in Healthy Subjects

• Status: Completed
• Trial end date: 2014-04-01

Summary

This is a nonrandomized, open-label, fixed-sequence, 2-arm study designed to assess the effect of multiple doses of fluconazole or atorvastatin on the single-dose pharmacokinetics of TAK-385 in healthy adult subjects.

• Phase: Phase 1

Details

• Lead Sponsor: Millennium Pharmaceuticals, Inc.
• Treatments: Atorvastatin; Atorvastatin Calcium; Fluconazole; Relugolix